A recently discovered virus in a Russian bat that is similar to SARS-CoV-2, the virus behind COVID-19, is likely capable of infecting humans and, if it were to spillover, is resistant to current vaccines.
Sep 22, 2022
0
130
The Centers for Disease Control and Prevention (CDC) recently released new recommendations for COVID-19 booster vaccinations. The shots, called bivalent vaccines, are designed to protect people from the original coronavirus ...
Sep 19, 2022
0
9
University of Alberta research shows how cell membranes play a much larger role than previously understood in allowing spike proteins on viruses to infect cells. The findings, published in the journal iScience, could give ...
Sep 16, 2022
0
74
A large team of researchers at the University of Texas Medical Branch, working with two colleagues from the University of Pennsylvania Perelman School of Medicine and two with the Mayo Clinic, has developed a vaccine for ...
Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity ...
Sep 8, 2022
0
72
As public health officials around the world contend with the latest surge of the COVID-19 pandemic, researchers at Drexel University have created a computer model that could help them be better prepared for the next one. ...
Sep 1, 2022
1
72
Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms ...
Aug 19, 2022
0
88
Researchers at the University of British Columbia have discovered a key vulnerability across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 Omicron subvariants.
Aug 18, 2022
0
98
Findings from a new study at the Marshall University Joan C. Edwards School of Medicine show that a thymidine phosphorylase (TYMP) inhibitor could help slow thrombosis in COVID-19 patients.
Aug 16, 2022
0
17
As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially omicron, have developed ways to evade the antibodies we make in response ...
Aug 11, 2022
0
170
